104 related articles for article (PubMed ID: 4660712)
21. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.
Golde WT; Pacheco JM; Duque H; Doel T; Penfold B; Ferman GS; Gregg DR; Rodriguez LL
Vaccine; 2005 Dec; 23(50):5775-82. PubMed ID: 16153756
[TBL] [Abstract][Full Text] [Related]
22. [Efficacy of foot-and-mouth disease vaccine in pigs treated with formaldehyde GOA saponin prepared with A22 foot-and-mouth virus].
Sobko AI; Sokolov LN; Belokon IK; Prokhorov VN; Tcherniaev IA; Sidorov IV
Bull Off Int Epizoot; 1972; 77(5):791-802. PubMed ID: 4676697
[No Abstract] [Full Text] [Related]
23. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
Foord AJ; Muller JD; Yu M; Wang LF; Heine HG
J Immunol Methods; 2007 Apr; 321(1-2):142-51. PubMed ID: 17328909
[TBL] [Abstract][Full Text] [Related]
24. [Determination of effectiveness of FMD vaccine type Asia 1 in neutralization tests in cattle].
Dimitriadis IA
Berl Munch Tierarztl Wochenschr; 1993 Apr; 106(4):124-7. PubMed ID: 8387775
[TBL] [Abstract][Full Text] [Related]
25. [Control of efficacy of foot-and-mouth disease vaccine prepared for swine].
Fédida M; Coudert M; Dannacher G; Peillon M
Bull Off Int Epizoot; 1972; 77(5):821-38. PubMed ID: 4676699
[No Abstract] [Full Text] [Related]
26. Vaccination against foot-and-mouth disease.
Morgan DO; Moore DM; McKercher PD
Prog Clin Biol Res; 1980; 47():169-78. PubMed ID: 6259663
[No Abstract] [Full Text] [Related]
27. The use of vaccines in South American foot-and-mouth disease eradication programmes.
Saraiva V; Darsie G
Dev Biol (Basel); 2004; 119():33-40. PubMed ID: 15742616
[TBL] [Abstract][Full Text] [Related]
28. Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs.
Eblé PL; de Bruin MG; Bouma A; van Hemert-Kluitenberg F; Dekker A
Vaccine; 2006 Feb; 24(9):1274-81. PubMed ID: 16289709
[TBL] [Abstract][Full Text] [Related]
29. Optimization strategy for plasmid DNAs containing multiple-epitopes of foot-and-mouth disease virus by cis-expression with IL-2.
Zhang HY; Sun SH; Guo YJ; Zhu WJ; Shi K; Xu GX; Wang JJ
Vaccine; 2008 Feb; 26(6):769-77. PubMed ID: 18191307
[TBL] [Abstract][Full Text] [Related]
30. Foot-and-mouth disease control using vaccination: South African experience.
Brückner GK; Vosloo W; Cloete M; Dungu B; Du Plessis BJ
Dev Biol (Basel); 2004; 119():51-62. PubMed ID: 15742618
[TBL] [Abstract][Full Text] [Related]
31. [Statistical evaluation of allergic reactions following vaccinations against foot-and-mouth-disease in 1968-69].
Lorenz RJ; Straub OC
Zentralbl Bakteriol Orig; 1971; 216(4):448-65. PubMed ID: 5104307
[No Abstract] [Full Text] [Related]
32. [Vaccination against foot and mouth disease: current state and perspectives].
Visser N; Thiel HJ
Dtsch Tierarztl Wochenschr; 2001 Dec; 108(12):522-5. PubMed ID: 11822168
[TBL] [Abstract][Full Text] [Related]
33. Ginseng stem-leaf saponins (GSLS) and mineral oil act synergistically to enhance the immune responses to vaccination against foot-and-mouth disease in mice.
Song X; Bao S; Wu L; Hu S
Vaccine; 2009 Jan; 27(1):51-5. PubMed ID: 18973783
[TBL] [Abstract][Full Text] [Related]
34. [Immunogenic properties of foot-and-mouth vaccines].
Tekerlekov P; Nikolova E; Dilovski M
Vet Med Nauki; 1983; 20(5-6):46-51. PubMed ID: 6318424
[TBL] [Abstract][Full Text] [Related]
35. Non-capsid proteins to identify foot-and-mouth disease viral circulation in cattle irrespective of vaccination.
Bergmann IE; Malirat V; Neitzert E
Biologicals; 2005 Dec; 33(4):235-9. PubMed ID: 16257539
[TBL] [Abstract][Full Text] [Related]
36. Use of new adjuvants in an emergency vaccine against foot-and-mouth disease virus: evaluation of conferred immunity.
Quattrocchi V; Bianco V; Fondevila N; Pappalardo S; Sadir A; Zamorano P
Dev Biol (Basel); 2004; 119():481-97. PubMed ID: 15742663
[TBL] [Abstract][Full Text] [Related]
37. Vaccination of pigs two weeks before infection significantly reduces transmission of foot-and-mouth disease virus.
Eblé PL; Bouma A; de Bruin MG; van Hemert-Kluitenberg F; van Oirschot JT; Dekker A
Vaccine; 2004 Mar; 22(11-12):1372-8. PubMed ID: 15063559
[TBL] [Abstract][Full Text] [Related]
38. Further evaluation of higher potency vaccines for early protection of cattle against FMDV direct contact challenge.
Cox SJ; Parida S; Voyce C; Reid SM; Hamblin PA; Hutchings G; Paton DJ; Barnett PV
Vaccine; 2007 Nov; 25(44):7687-95. PubMed ID: 17913309
[TBL] [Abstract][Full Text] [Related]
39. [Nature, extent and causes of vaccination complications following foot-and-mouth disease vaccination from 1967 to 1968 in Bavaria].
Mayr A; Ringseisen J; Baljer G; Bibrack B; Wallner J; Zimmer H
Zentralbl Veterinarmed B; 1969 Aug; 16(6):488-511. PubMed ID: 5349563
[No Abstract] [Full Text] [Related]
40. Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle.
Cox SJ; Voyce C; Parida S; Reid SM; Hamblin PA; Hutchings G; Paton DJ; Barnett PV
Vaccine; 2006 Apr; 24(16):3184-90. PubMed ID: 16488060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
